Impact of Daratumumab Refractoriness on Clinical Outcomes Following CAR T-cell Therapy for Relapsed/Refractory Multiple Myeloma

被引：0

作者：

Costa, Bruno ^{[1
]}

Rajeeve, Sridevi ^{[2
]}

Jurgens, Eric ^{[3
]}

Nishimura, Noriko ^{[4
]}

Farzana, Tasmin ^{[4
]}

Firestone, Ross ^{[4
]}

Miller, Kevin ^{[4
]}

Lesokhin, Alexander ^{[2
]}

Shah, Gunjan ^{[5
]}

Korde, Neha ^{[2
]}

Tan, Carlyn ^{[2
]}

Chung, David ^{[5
]}

Landau, Heather ^{[5
]}

Scordo, Michael ^{[5
]}

Hassoun, Hani

Maclachlan, Kylee ^{[4
]}

Shah, Urvi ^{[2
]}

Hultcrantz, Malin ^{[2
]}

Hamadeh, Issam ^{[4
]}

Giralt, Sergio ^{[5
]}

Mailankody, Sham ^{[2
]}

Usmani, Saad ^{[2
]}

Hashmi, Hamza ^{[2
]}

机构：

[1] Icahn Sch Med Mt Sinai, New York, NY 10029 USA

[2] Mem Sloan Kettering Canc Ctr, Dept Med, Myeloma Serv, New York, NY 10021 USA

[3] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA

[4] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA

[5] Mem Sloan Kettering Canc Ctr, Dept Med, Adult Bone Marrow Transplant Serv, New York, NY 10021 USA

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P-011

引用

页码：S46 / S46

页数：1